Essential Site Maintenance: Authorea-powered sites will be updated circa 15:00-17:00 Eastern on Tuesday 5 November.
There should be no interruption to normal services, but please contact us at [email protected] in case you face any issues.

loading page

Multimodal retinal imaging in leukemic retinopathy in children with chronic myeloid leukemia
  • +7
  • Francisco Olguin-Manriquez,
  • Cristina del Prado Sánchez,
  • Jaume Català-Mora,
  • Jorge Sanchez Molina,
  • Anna Ruiz Llobet,
  • Anna Faura Morros,
  • Nuria Conde Cuevas,
  • Laura Arques,
  • Fernando Rafael Aguirregomezcorta,
  • Albert Catalá
Francisco Olguin-Manriquez
Hospital Sant Joan de Deu

Corresponding Author:[email protected]

Author Profile
Cristina del Prado Sánchez
Hospital Sant Joan de Deu
Author Profile
Jaume Català-Mora
Hospital Sant Joan de Deu
Author Profile
Jorge Sanchez Molina
Hospital Universitario de Donostia
Author Profile
Anna Ruiz Llobet
Institut de Recerca Sant Joan de Deu
Author Profile
Anna Faura Morros
Institut de Recerca Sant Joan de Deu
Author Profile
Nuria Conde Cuevas
Institut de Recerca Sant Joan de Deu
Author Profile
Laura Arques
Institut de Recerca Sant Joan de Deu
Author Profile
Fernando Rafael Aguirregomezcorta
Institut de Recerca Sant Joan de Deu
Author Profile
Albert Catalá
Institut de Recerca Sant Joan de Deu
Author Profile

Abstract

Objective: To evaluate changes in multimodal retinal imaging of patients with chronic myeloid leukemia. Methods: Observational case series study. All patients underwent a complete ophthalmic examination and were imaged with multimodal imaging before and after therapy for CML. Results: Mean age at diagnosis was 15 years old. All patients were male. The retinal findings at diagnosis were foveal infiltrates in 66.6%, retinal infiltration in 66.6%, venous dilation and arterial tortuosity in 66.6%, retinal hemorrhages in 100%, pre-retinal hemorrhages 33.3%, cotton-wool spots in 66.6%, Roth’s spots in 100%. Mean follow-up was 94.6 weeks (range 20-150 weeks). Regression of LR was completed after 100 days (range 56-170 days), and regression of macular infiltrates, at day 19 (range 17-21 days). Conclusion: MRI can provide relevant information when monitoring clinical response for systemic conditions affecting the eyes. At first, foveal infiltrates tend to disappear once the induction therapy has started. Retinal hemorrhages, vascular dilation, retinal infiltrates, and cotton wool spots tend to gradually disappear associated to the reduction of mature cells into the blood stream and the achievement of a major molecular response (MMR) assessed by TR-PCR.